SCANGOS GEORGE A 4
4 · Vir Biotechnology, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
SCANGOS GEORGE A
Director
Transactions
- Sale
Common Stock
2025-02-24$9.45/sh−10,056$95,063→ 698,239 total
Holdings
- 1,151,730(indirect: See footnote)
Common Stock
- 598,270(indirect: See footnote)
Common Stock
- 1,151,730(indirect: See footnote)
Common Stock
- 33,629(indirect: See footnote)
Common Stock
- 179,930(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F3]The shares are held by the spouse of the Reporting Person.
- [F4]The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F5]The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
- [F6]The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.